Intensive care medicine

Malaria

Neuroscience

Biology

Drug resistance

Blood–brain barrier

Psychiatry

Drug

Plasmodium falciparum

Cerebral Malaria

Immunology

Central nervous system

Microbiology

Internal medicine

Pharmacology

Intervention (counseling)

Medicine

Disease

Pathogenesis

Pathology

Trends in Parasitology

Cerebral malaria is a life-threatening complication of malaria caused by the parasite Plasmodium falciparum. The growing problem of drug resistance and the dearth of new antiparasitic drugs are a serious threat to the antimalaria treatment regimes. Studies on humans and the murine model have implicated the disruption of the blood-brain barrier (BBB) in the lethal course of the disease. Therefore, efforts to alleviate the BBB dysfunction could serve as an adjunct therapy. Here, we review the mechanisms associated with the disruption of the BBB. In addition, we discuss the current, still limited, knowledge on the contribution of different cell types, microparticles, and the kynurenine pathway in the regulation of BBB dysfunction, and how these molecules could be used as potential new therapeutic targets.

Blood–Brain Barrier in Cerebral Malaria: Pathogenesis and Therapeutic Intervention